A detailed history of Russell Investments Group, Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 737 shares of IGMS stock, worth $12,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
737
Previous 75 882.67%
Holding current value
$12,720
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$6.51 - $11.47 $4,309 - $7,593
662 Added 882.67%
737 $5,000
Q4 2023

Feb 05, 2024

SELL
$3.94 - $8.79 $82 - $184
-21 Reduced 21.88%
75 $0
Q3 2023

Nov 13, 2023

BUY
$6.66 - $10.64 $639 - $1,021
96 New
96 $0
Q1 2022

May 05, 2022

SELL
$13.42 - $29.73 $340,129 - $753,506
-25,345 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$27.59 - $66.39 $260,891 - $627,783
-9,456 Reduced 27.17%
25,345 $742,000
Q3 2021

Nov 08, 2021

BUY
$65.76 - $90.65 $57,474 - $79,228
874 Added 2.58%
34,801 $2.29 Million
Q2 2021

Aug 04, 2021

BUY
$57.98 - $96.6 $1.45 Million - $2.41 Million
24,998 Added 279.96%
33,927 $2.82 Million
Q1 2021

May 10, 2021

SELL
$71.56 - $121.23 $195,072 - $330,472
-2,726 Reduced 23.39%
8,929 $684,000
Q4 2020

Feb 08, 2021

BUY
$47.41 - $115.03 $552,563 - $1.34 Million
11,655 New
11,655 $1.03 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.